scholarly journals The dipeptidyl peptidase-4 inhibitor teneligliptin reduces kidney damage from hypercholesterolemia in apolipoprotein E-deficient mice

RSC Advances ◽  
2017 ◽  
Vol 7 (14) ◽  
pp. 8702-8708 ◽  
Author(s):  
Hui Liu ◽  
Nan Li ◽  
Ying Liu ◽  
Jing Xing ◽  
Shuai Feng ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Risk Factor ◽  
Kidney Disease ◽  
Apolipoprotein E ◽  
Kidney Injury ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Established Risk Factor ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Deficient Mice

Hypercholesterolemia is a well-established risk factor for kidney injury that can lead to chronic kidney disease (CKD).

scholarly journals Thymoquinone reduces kidney damage in apolipoprotein E-deficient mice fed a high-cholesterol diet

RSC Advances ◽  
2017 ◽  
Vol 7 (83) ◽  
pp. 53002-53009
Author(s):  
Zuowei Pei ◽  
Liyue Zhu ◽  
Yingshu Liu ◽  
Nan Li ◽  
Guang Yang ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Risk Factor ◽  
Therapeutic Agent ◽  
Kidney Injury ◽  
Kidney Damage ◽  
High Cholesterol Diet ◽  
Cholesterol Diet ◽  
High Cholesterol ◽  
Established Risk Factor ◽  
Deficient Mice

Hypercholesterolemia is a well-established risk factor for kidney injury that can lead to chronic kidney disease (CKD). Thymoquinone may be a potential therapeutic agent for kidney damage from hypercholesterolemia.

Sign in / Sign up

Export Citation Format

Share Document